Why the study?
Can dilated cardiomyopathy be the only clinical manifestation in female carriers of Duchenne muscular dystrophy?
Can dilated cardiomyopathy be the only clinical manifestation in female carriers of Duchenne muscular dystrophy?
Dilated cardiomyopathy can be the sole clinical manifestation of dystrophin gene mutation in female carriers of Duchenne muscular dystrophy.
Answers are grounded in this paper and cite their sources.
May support dystrophin testing in unexplained female DCM; hypothesis-generating, requires larger studies before practice change.
Cardiomyopathy was reported in a few Duchenne muscular dystrophy (DMD) carriers with clinical evidence of myopathy. We report two carriers with dilated cardiomyopathy, increased serum CK, and no symptoms of muscle weakness. In heart biopsies of both patients, dystrophin-the protein product of DMD locus--was absent in many fibers. Dilated cardiomyopathy may be the only manifestation of dystrophin gene mutation in carriers.
No takes yet. Share an insight, caveat, or question.
Mirabella et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: